Tech Company Financing Transactions

Montigen Pharmaceuticals Funding Round

Private investors invested in a $5.2 million funding round for Montigen Pharmaceuticals. This VC investment round was announced on 6/30/2005.

Transaction Overview

Announced On
6/30/2005
Transaction Type
Venture Equity
Amount
$5,200,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2401 South Foothill Drive
Salt Lake City, UT 84109
USA
Email Address
Overview
Montigen Pharmaceuticals is a small molecule drug discovery and development company.
Profile
Montigen Pharmaceuticals LinkedIn Company Profile
Social Media
Montigen Pharmaceuticals Company Twitter Account
Company News
Montigen Pharmaceuticals News
Facebook
Montigen Pharmaceuticals on Facebook
YouTube
Montigen Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dallin Anderson
  Dallin Anderson LinkedIn Profile  Dallin Anderson Twitter Account  Dallin Anderson News  Dallin Anderson on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2005: Proofpoint venture capital transaction
Next: 6/30/2005: Allconnect venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary